Oral Communications and Posters
Vol. 5 No. s3 (2026): Abstracts of the XXIX National Congress of the Italian Society for the Study of Hemostasis and Thrombosis, 2026

PO016 | TOLL-LIKE RECEPTOR 4-MEDIATED ENDOTHELIAL DYSFUNCTION VIA NOX2 ACTIVATION IN COVID-19

C. Nocella1|2, V. Castellani2, L. Loffredo1, V. Cammisotto1, S. Bartimoccia1, P. Pignatelli1, R. Carnevale3|4, F. Violi1 | 1Dip di Scienze Mediche e Cardiovascolari, Sapienza Università di Roma, Italy; 2Fondazione Cenci Bolognetti, Istituto Pasteur Italia, Italy; 3IRCCS Neuromed, Italy; 4Dip di Scienze e Biotecnologie Medico-Chirurgiche, Sapienza Università di Roma, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 26 October 2026
0
Views
0
Downloads

Authors

Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with endothelial dysfunction. Multiple pathophysiological mechanisms have been proposed, including direct endothelial infection and indirect injury mediated by systemic inflammation. However, alternative receptors involved in SARS-CoV-2–induced endothelial damage remain to be fully elucidated. We hypothesized that the SARS-CoV-2 Spike protein contributes to endothelial dysfunction via Toll-like receptor 4 (TLR4)-mediated oxidative stress.
Methods. We studied 20 patients with SARS-CoV-2 infection. Endothelial function was assessed by flow-mediated dilation (FMD). Serum levels of Spike protein and TNF-α were measured. In vitro, human umbilical vein endothelial cells (HUVECs) were incubated with recombinant Spike protein, TNF-α, or both, in the presence or absence of specific inhibitors of TLR4, NOX2, p47phox, PKC, and ACE2. Markers of endothelial activation (NO bioavailability, endothelin-1) and oxidative stress (H₂O₂, sNOX2-dp, p47phox phosphorylation) were evaluated.
Results. Compared with controls, COVID-19 patients exhibited significantly reduced FMD. Linear regression analysis in the overall population showed that FMD inversely correlated with serum Spike protein and TNF-α levels. A significant positive correlation between TNF-α and Spike protein was also observed. In vitro, S protein (250 and 500 ng/mL) reduced nitric oxide (NO) bioavailability and significantly increased endothelin-1 levels compared with unstimulated HUVECs. These effects were attenuated by TLR4 or p47phox inhibition, whereas ACE2 inhibition (DX600) had no impact. Mechanistically, S protein increased H₂O₂ production, sNOX2-dp levels, p47phox, and PKC phosphorylation in a dose-dependent manner. NOX2 activation and p47phox phosphorylation were reduced by TLR4 or p47phox inhibitors, while ACE2 inhibition did not affect S protein–induced oxidative stress. Exposure of HUVECs to TNF-α alone, at concentrations comparable to those observed in patients, or to S protein alone induced endothelial activation and oxidative stress. Co-incubation with TNF-α and S protein further amplified these effects, which were significantly reduced by inhibition of TLR4, S protein, TNF-α, or p47phox.
Conclusions. The Spike protein directly induces endothelial oxidative stress and dysfunction through a TLR4–NOX2–p47phox signaling pathway, independently of ACE2. TNF-α synergistically enhances these effects. These findings identify TLR4-mediated signaling as a key mechanism underlying COVID-19–related vascular damage and suggest potential therapeutic targets to prevent thrombotic complications.

Downloads

Download data is not yet available.

Citations

How to Cite



1.
Nocella C. PO016 | TOLL-LIKE RECEPTOR 4-MEDIATED ENDOTHELIAL DYSFUNCTION VIA NOX2 ACTIVATION IN COVID-19: C. Nocella1|2, V. Castellani2, L. Loffredo1, V. Cammisotto1, S. Bartimoccia1, P. Pignatelli1, R. Carnevale3|4, F. Violi1 | 1Dip di Scienze Mediche e Cardiovascolari, Sapienza Università di Roma, Italy; 2Fondazione Cenci Bolognetti, Istituto Pasteur Italia, Italy; 3IRCCS Neuromed, Italy; 4Dip di Scienze e Biotecnologie Medico-Chirurgiche, Sapienza Università di Roma, Italy. Bleeding Thromb Vasc Biol [Internet]. 2026 Oct. 26 [cited 2026 Oct. 28];5(s3). Available from: https://www.btvb.org/btvb/article/view/832